HIGHLIGHTS
- who: . and collaborators from the Kazi Nazrul University, India have published the paper: Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments, in the Journal: (JOURNAL)
- what: This study has implications for the COVID19treatment and prevention: applying TLR2 antagonists such as oxPAPC in patients with outbreaks of excessive inflammation may reduce the inflammatory response and possibly improve the cure rates of patients (Zheng et_al, 2021).
- how: In the review the SARS-CoV-2 invasion and pathogenic molecular mechanisms the roles of different TLRs in SARS-CoV-2 infection and whether agonists . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.